168 related articles for article (PubMed ID: 20668647)
21. Developments towards effective treatments for Nipah and Hendra virus infection.
Bossart KN; Broder CC
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):43-55. PubMed ID: 16441208
[TBL] [Abstract][Full Text] [Related]
22. Henipaviruses at the Interface Between Bats, Livestock and Human Population in Africa.
Mbu'u CM; Mbacham WF; Gontao P; Sado Kamdem SL; Nlôga AMN; Groschup MH; Wade A; Fischer K; Balkema-Buschmann A
Vector Borne Zoonotic Dis; 2019 Jul; 19(7):455-465. PubMed ID: 30985268
[TBL] [Abstract][Full Text] [Related]
23. Henipaviruses: an updated review focusing on the pteropid reservoir and features of transmission.
Clayton BA; Wang LF; Marsh GA
Zoonoses Public Health; 2013 Feb; 60(1):69-83. PubMed ID: 22709528
[TBL] [Abstract][Full Text] [Related]
24. Henipavirus infections: lessons from animal models.
Dhondt KP; Horvat B
Pathogens; 2013 Apr; 2(2):264-87. PubMed ID: 25437037
[TBL] [Abstract][Full Text] [Related]
25. Henipavirus: a review of laboratory animal pathology.
Williamson MM; Torres-Velez FJ
Vet Pathol; 2010 Sep; 47(5):871-80. PubMed ID: 20682803
[TBL] [Abstract][Full Text] [Related]
26. Novel Roles of the N1 Loop and N4 Alpha-Helical Region of the Nipah Virus Fusion Glycoprotein in Modulating Early and Late Steps of the Membrane Fusion Cascade.
Zamora JLR; Ortega V; Johnston GP; Li J; Aguilar HC
J Virol; 2021 Apr; 95(9):. PubMed ID: 33568505
[TBL] [Abstract][Full Text] [Related]
27. Henipavirus pathogenesis and antiviral approaches.
Mathieu C; Horvat B
Expert Rev Anti Infect Ther; 2015 Mar; 13(3):343-54. PubMed ID: 25634624
[TBL] [Abstract][Full Text] [Related]
28. Hendra and Nipah viruses: why are they so deadly?
Marsh GA; Wang LF
Curr Opin Virol; 2012 Jun; 2(3):242-7. PubMed ID: 22483665
[TBL] [Abstract][Full Text] [Related]
29. Understanding the interaction between henipaviruses and their natural host, fruit bats: Paving the way toward control of highly lethal infection in humans.
Enchéry F; Horvat B
Int Rev Immunol; 2017 Mar; 36(2):108-121. PubMed ID: 28060559
[TBL] [Abstract][Full Text] [Related]
30. Hendra and Nipah Virus Infection in Cultured Human Olfactory Epithelial Cells.
Borisevich V; Ozdener MH; Malik B; Rockx B
mSphere; 2017; 2(3):. PubMed ID: 28680971
[TBL] [Abstract][Full Text] [Related]
31. An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections.
Dang HV; Chan YP; Park YJ; Snijder J; Da Silva SC; Vu B; Yan L; Feng YR; Rockx B; Geisbert TW; Mire CE; Broder CC; Veesler D
Nat Struct Mol Biol; 2019 Oct; 26(10):980-987. PubMed ID: 31570878
[TBL] [Abstract][Full Text] [Related]
32. Targeted strategies for henipavirus therapeutics.
Bossart KN; Bingham J; Middleton D
Open Virol J; 2007; 1():14-25. PubMed ID: 19440455
[TBL] [Abstract][Full Text] [Related]
33. Nipah virus attachment glycoprotein stalk C-terminal region links receptor binding to fusion triggering.
Liu Q; Bradel-Tretheway B; Monreal AI; Saludes JP; Lu X; Nicola AV; Aguilar HC
J Virol; 2015 Feb; 89(3):1838-50. PubMed ID: 25428863
[TBL] [Abstract][Full Text] [Related]
34. Nuclear localization and secretion competence are conserved among henipavirus matrix proteins.
McLinton EC; Wagstaff KM; Lee A; Moseley GW; Marsh GA; Wang LF; Jans DA; Lieu KG; Netter HJ
J Gen Virol; 2017 Apr; 98(4):563-576. PubMed ID: 28056216
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of Nipah virus and Hendra virus replication in different cell lines and their suitability for antiviral screening.
Aljofan M; Saubern S; Meyer AG; Marsh G; Meers J; Mungall BA
Virus Res; 2009 Jun; 142(1-2):92-9. PubMed ID: 19428741
[TBL] [Abstract][Full Text] [Related]
36. Fc-Based Recombinant Henipavirus Vaccines Elicit Broad Neutralizing Antibody Responses in Mice.
Li Y; Li R; Wang M; Liu Y; Yin Y; Zai X; Song X; Chen Y; Xu J; Chen W
Viruses; 2020 Apr; 12(4):. PubMed ID: 32340278
[TBL] [Abstract][Full Text] [Related]
37. Henipaviruses: recent observations on regulation of transcription and the nature of the cell receptor.
Eaton BT; Wright PJ; Wang LF; Sergeyev O; Michalski WP; Bossart KN; Broder CC
Arch Virol Suppl; 2004; (18):122-31. PubMed ID: 15119767
[TBL] [Abstract][Full Text] [Related]
38. Henipaviruses: a new family of emerging Paramyxoviruses.
Wild TF
Pathol Biol (Paris); 2009 Mar; 57(2):188-96. PubMed ID: 18511217
[TBL] [Abstract][Full Text] [Related]
39. Antiviral activity of gliotoxin, gentian violet and brilliant green against Nipah and Hendra virus in vitro.
Aljofan M; Sganga ML; Lo MK; Rootes CL; Porotto M; Meyer AG; Saubern S; Moscona A; Mungall BA
Virol J; 2009 Nov; 6():187. PubMed ID: 19889218
[TBL] [Abstract][Full Text] [Related]
40. Detailed Molecular Biochemistry for Novel Therapeutic Design Against Nipah and Hendra Virus: A Systematic Review.
Bhattacharya S; Dhar S; Banerjee A; Ray S
Curr Mol Pharmacol; 2020; 13(2):108-125. PubMed ID: 31657692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
